Gui Pi Tang
Natural health product licensed in Canada
- Licence holder
- Hummingbird Medical Tech Inc.
- NPN or DIN-HM
- 80052307
- Status
- Active licence
- Licence date
- 8 July 2014
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Conditions légales
Glycyrrhiza uralensis Fisch.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Panax ginseng Source : Rhizome et racine(s) Extract : Extract Type TBA Extraction ratio : 4.3:1 Dry plant equivalent : 111 mg | 26 mg | Not calculated |
| Dimocarpus longan Source : Seed aril Extract : Extract Type TBA Extraction ratio : 4.3:1 Dry plant equivalent : 111 mg | 26 mg | Not calculated |
| Astragalus membranaceus Source : Racine Extract : Extract Type TBA Extraction ratio : 4.3:1 Dry plant equivalent : 111 mg | 26 mg | Not calculated |
| Glycyrrhiza uralensis Source : Rhizome et racine(s) Extract : Extract Type TBA Extraction ratio : 4.3:1 Dry plant equivalent : 56 mg | 13 mg | Not calculated |
| Atractylodes macrocephala Source : Rhizome Extract : Extract Type TBA Extraction ratio : 4.3:1 Dry plant equivalent : 111 mg | 26 mg | Not calculated |
| Wolfiporia extensa Source : Sclerotium Extract : Extract Type TBA Extraction ratio : 4.3:1 Dry plant equivalent : 111 mg | 26 mg | Not calculated |
| Saussurea costus Source : Racine Extract : Extract Type TBA Extraction ratio : 4.3:1 Dry plant equivalent : 56 mg | 13 mg | Not calculated |
| Angelica sinensis Source : Racine Extract : Extract Type TBA Extraction ratio : 4.3:1 Dry plant equivalent : 111 mg | 26 mg | Not calculated |
| Ziziphus jujuba Source : Graine(s) Extract : Extract Type TBA Extraction ratio : 4.3:1 Dry plant equivalent : 111 mg | 26 mg | Not calculated |
| Polygala tenuifolia Source : Racine Extract : Extract Type TBA Extraction ratio : 4.3:1 Dry plant equivalent : 111 mg | 26 mg | Not calculated |
| Zingiber officinale Source : Rhizome Extract : Extract Type TBA Extraction ratio : 4.3:1 Dry plant equivalent : 74 mg | 17 mg | Not calculated |
| Ziziphus jujuba Source : Fruit Extract : Extract Type TBA Extraction ratio : 4.3:1 Dry plant equivalent : 74 mg | 17 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Amidon de maïs
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 4 Capsule ; maximum: 8 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Product based on Traditional Chinese Medicine theory.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80052307
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.